The new Quest Diagnostics Drug Testing Index (DTI) report is based on more than 10.6 million deidentified urine, hair and oral-fluid drug test results reported between January and December 2022, aimed at providing insight into behavior seen in workers across the combined U.S. “As employers express concern for employee health, wellness and safety, they may want to consider these data as a warning sign, particularly as a growing body of science demonstrates the risks of marijuana to mental and physical health.” “Year-over-year and five-year data point to continuously higher workforce drug positivity overall, by industry, and across multiple drug categories,” said Suhash Harwani, PhD, Senior Director of Science for Employer Solutions at Quest Diagnostics. “As employers express concern for employee health, wellness and safety, they may want to consider these data as a warning sign.” - Dr. Over the past five years, the workforce positivity rate climbed in most industry sectors, led by Accommodation and Food Services increasing 42.9% (4.9% in 2018 versus 7.0% in 2022), Retail Trade increasing 42.6% (5.4% in 2018 versus 7.7% in 2022), and Finance and Insurance increasing 38.5% (2.6% in 2018 versus 3.6% in 2022). The rising overall drug positivity rate for general workforce urine testing was observed widely across U.S. While the company’s amphetamines data does not differentiate between prescribed medications and illicit drug use, the increase correlates with other data suggesting that the use of amphetamines, prescribed or illicit, has grown in recent years in the U.S. workforce increased to 4.3% positivity in 2022 versus 3.9% positivity in 2021, and amphetamines positivity increased to 1.5% positivity in 2022 versus 1.3% positivity in 2021. Positivity for marijuana in the general U.S. workforce, amphetamines positivity also contributed to the increase.
HIGH ON THE JOB DRIVER
While marijuana was the main driver of workforce positivity increases in the general U.S. The 20 positivity rates were the highest since 2001, up more than 30% from an all-time low in 2010-2012. workforce urine drug positivity for all drugs persisted at 4.6% – the highest level in two decades.
HIGH ON THE JOB PRO
Which companies in the custom integration market made CE Pro's 24th annual CE Pro 100 list? It is imperative employers take the proper steps to create and maintain a policy that addresses cannabis use, build a safety-focused culture and educate the workforce to keep all workers safe on and off the job.” “The Quest data provide compelling evidence that increased use of cannabis products by employees can contribute to greater risk for injuries in the workplace. State legalization of the drug creates new challenges for employers,” said Katie Mueller, a senior program manager at the National Safety Council focusing on cannabis safety. “Intoxicating cannabis products, including marijuana, can have a major impact on safety at work and have been proven to slow reaction time, impact memory and impair skills essential to driving. “It is imperative employers take the proper steps to create and maintain a policy that addresses cannabis use, build a safety-focused culture and educate the workforce to keep all workers safe on and off the job.” - Katie Mueller, National Safety Council Since then, 19 additional states and the District of Columbia have legalized the recreational use of marijuana and 38 states (plus the District of Columbia) have legalized medical use, although either kind of use remains illegal under federal law. In 2012, Colorado and Washington became the first states to legalize marijuana for recreational use. These increases in post-accident marijuana positivity correspond with legalization of marijuana in certain states. workforce tests positive for marijuana while on the job, regardless of an accident occurring or not. From 2002 to 2009, post-accident marijuana workforce positivity declined. In that 10-year time frame, post-accident marijuana positivity increased 204.2%. The new peak follows a steady increase in post-accident marijuana positivity every year from 2012 to 2022. workforce was 7.3%, an increase from 6.7% in 2021.
According to a new analysis released today by Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, in 2022, post-accident marijuana positivity of urine drug tests in the general U.S.
0 kommentar(er)
